Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases

Core Insights - Inari Medical, now part of Stryker, has launched the Artix Thrombectomy System, designed specifically for the peripheral arterial system, aiming to set a new standard for arterial thrombectomy [1][2][4] Product Overview - The Artix Thrombectomy System combines aspiration and mechanical thrombectomy, providing procedural control and versatility for treating arterial blood clots [1][2] - It is Inari's first product targeting the arterial space, building on the success of its venous thrombectomy devices [2][4] Clinical Significance - The system addresses a critical clinical need for effective treatment of chronic thrombi and aims to reduce the risk of clot migration [4] - Dr. Jonathan Bowman, who performed the first commercial case, highlighted its effectiveness in managing a wide range of clots while maintaining vessel access [3][4] Key Features - The Artix system includes a dual mechanical thrombectomy and aspiration toolkit, designed to remove acute to chronic clots in a single session [7] - It features an 8 Fr. low profile, trackable, kink-resistant sheath available in 65cm and 90cm lengths, enhancing treatment options for complex interventions [7] - The innovative over-the-wire mechanical element is designed to effectively collect and retrieve clots, while a covered nitinol mesh funnel minimizes the risk of arterial clot migration during procedures [7][9] Company Background - Stryker, a global leader in medical technologies, acquired Inari Medical on February 19, 2025, to enhance its portfolio in treating venous and arterial diseases [5][4] - Stryker impacts over 150 million patients annually through its innovative products and services across various medical fields [4]